Skip to main content Skip to section navigation Skip to footer

ClearPoint Neuro, Inc.

Investor Relations

  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • clearpointneuro.com
This website uses cookies to improve your experience. ACCEPT REJECT

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Oct 07, 2025 4:15pm EDT

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 06, 2025 4:10pm EDT

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 01, 2025 4:05pm EDT

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025 4:05pm EDT

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 04, 2025 4:05pm EDT

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 12, 2025 4:05pm EDT

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 04, 2025 4:05pm EDT

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025 4:05pm EDT

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

May 13, 2025 4:40pm EDT

ClearPoint Neuro Reports First Quarter 2025 Results

May 12, 2025 4:05pm EDT

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 36
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
ClearPoint Neuro, Inc. Youtube ClearPoint Neuro, Inc. Facebook ClearPoint Neuro, Inc. Twitter ClearPoint Neuro, Inc. LinkedIn ClearPoint Neuro, Inc. Instagram
©2025 ClearPoint Neuro, Inc. All Rights Reserved.
Privacy Policy Cookie Policy Terms of Use California Compliance Declaration Sitemap